BioNTech’s Founders Will Leave to Start New Firm With mRNA Focus
BioNTech SE’s founders will leave the company to start a new biotech focused on messenger RNA, the technology behind their blockbuster Covid-19 vaccine.
By Sonja Wind, Naomi Kresge · Bloomberg
BioNTech SE’s founders will leave the company to start a new biotech focused on messenger RNA, the technology behind their blockbuster Covid-19 vaccine.